Page 644 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 644

C H A P T E R          40 

           THALASSEMIA SYNDROMES


           John Chapin and Patricia J. Giardina





        The thalassemia syndromes are a heterogeneous group of inherited   sickle  cell  anemia),  which  are  characterized  by  the  production  of
        anemias characterized by defects in the synthesis of one or more of   normal amounts of mutant globin chains having deranged physical
        the  globin  chain  subunits  of  the  hemoglobin  (Hb)  tetramer. The   or chemical properties, the thalassemias are quantitative disorders: the
        clinical syndromes associated with thalassemia arise from the com-  primary lesion lies in the amount of globin produced. However, some
        bined consequences of inadequate Hb production and imbalanced   rare  forms  of  thalassemia  are  characterized  by  the  production  of
        accumulation  of  globin  subunits. The  former  causes  hypochromia   structurally abnormal globin chains in reduced amounts, which are
        and microcytosis; the latter leads to ineffective erythropoiesis (IE) and   described in more detail in this chapter. These thalassemic hemoglo-
        hemolytic anemia. Clinical manifestations are diverse, ranging from   binopathies share features of thalassemia as well as those of structural
        asymptomatic hypochromia and microcytosis to profound anemia,   hemoglobinopathies. 6
        which can be fatal in utero or in early childhood if untreated. This   Some mutations alter the patterns of fetal to adult Hb switching.
        heterogeneity arises from the variable severities of the primary bio-  These conditions, called hereditary persistence of fetal Hemoglobin, are
        synthetic defects and coinherited modifying factors, such as increased   not  generally  associated  with  clinical  symptoms;  nonetheless,  they
        synthesis of fetal globin subunits or diminished or increased synthesis   merit consideration in this chapter. Their importance lies in their role
        of  α-globin  subunits.  Palliative  treatment  of  the  severe  forms  by   as modulating factors when coinherited with other hemoglobinopa-
        blood  transfusion  is  eventually  compromised  by  the  concomitant   thies. They are also useful models for investigating the molecular basis
        problems  of  iron  overload,  alloimmunization,  and  bloodborne   for globin gene regulation during human development and as para-
        infections.                                           digms for rational therapy for the major β-chain hemoglobinopathies,
           As a group, the thalassemias represent the most common single   namely, sickle cell anemia and β-thalassemia.
        genetic disorder known. In many parts of the world, they constitute
        major public health problems. Laboratory analysis of these disorders
        has been one of the most productive and enlightening endeavors of   ETIOLOGY, EPIDEMIOLOGY, AND PATHOPHYSIOLOGY
        biomedical research. Study of the molecular defects underlying the
        thalassemia  syndromes  has  led  to  fundamental  advances  in  our   Thalassemias have been encountered in virtually every ethnic group
        understanding of eukaryotic gene structure and function. For each of   and  geographic  location.  Thalassemia  carriers  affect  1.5%  of  the
        these reasons, a thorough understanding of thalassemia and its related   world  population.  They  are  most  common  in  the  Mediterranean
        disorders is essential to hematologists. This chapter reviews the major   basin  and  tropical  or  subtropical  regions  of  Asia  and  Africa. The
        features of these syndromes. Readers wanting more detailed informa-  “thalassemia belt” extends along the shores of the Mediterranean and
        tion than can be included here are referred to more comprehensive   throughout the Arabian peninsula, Turkey, Iran, India, southeastern
        monographs elsewhere. 1,2                             Asia,  especially Thailand,  Cambodia,  and  southern  China. 7–10  The
           The  classification,  genetic  basis,  and  pathophysiology  of  the   prevalence of carriers of thalassemia in these regions is in the range
        thalassemia syndromes are based on a thorough understanding of the   of 2.5% to 15%. Similar to sickle cell anemia, thalassemia is most
        human Hbs, their biosynthesis, their encoding globin gene families,   common in areas historically affected by endemic malaria. Malaria
        and  their  roles  as  soluble  oxygen-carrying  molecules.  Therefore,   seems to have conferred selective survival advantage to thalassemia
        readers  of  this  chapter  should  first  familiarize  themselves  with  the   heterozygotes in which infection with the malarial parasite is believed
        material  presented  in  Chapter  31. The  material  presented  in  this   to result in milder disease and less impact on reproductive fitness. 1,2,11
        chapter is also substantially clarified by prior reading of Chapters 33   Therefore, the gene frequency for thalassemia has become fixed and
        and 34 because the principles underlying the pathophysiology of and   high in populations exposed to malaria over many centuries.
        therapy  for  thalassemia  draw  heavily  on  knowledge  of  iron
        metabolism.
                                                              PATHOPHYSIOLOGY: GENERAL PRINCIPLES
        DEFINITIONS AND NOMENCLATURE                          The primary lesion in all forms of thalassemia is reduced or absent
                                                              production of one or more globin chains. For all practical purposes,
        The  term  thalassemia  is  derived  from  a  Greek  term  that  roughly   the  major  impact  on  clinical  well-being  occurs  only  when  these
                                           1
        means “the sea” (Mediterranean) in the blood.  It was first applied   lesions affect the α- or β-globin chains necessary for the synthesis of
        to the anemias frequently encountered in people from the Italian and   adult hemoglobin (Hb A), with a normal structure of α 2 β 2 . Severe
                                3–5
        Greek coasts and nearby islands.  The term is now used to refer to   impairment of γ-, ε-, or ζ-globin production is presumably lethal in
        inherited defects in globin-chain biosynthesis. Individual syndromes   utero, and has not been observed in human biology. One consequence
        are named according to the globin chain whose synthesis is adversely   of reduced globin-chain production is immediately apparent: reduced
        affected. Thus,  α-globin  chains  are  absent  or  reduced  in  patients   production of functioning Hb tetramers. As a result, hypochromia
        with α-thalassemia, β-globin chains in patients with β-thalassemia,   and microcytosis are characteristic of virtually all patients with thalas-
        δ-globin and β-globin chains in patients δβ-thalassemia, and so forth.   semia. In the milder forms of the disease, this phenomenon may be
        In some contexts, it is also useful to subclassify the syndromes accord-  barely detectable.
        ing to whether synthesis of the affected globin chain is totally absent   The second consequence of impaired globin biosynthesis is unbal-
                                                +
        (e.g., β°-thalassemia) or only partially reduced (e.g., β -thalassemia).  anced synthesis of the individual α- and β-subunits. Hb tetramers
           The most common forms of thalassemia arise from total absence   are  highly  soluble  and  have  reversible  oxygen-carrying  properties
        of structurally normal globin chains or a partial reduction in their   exquisitely adapted for oxygen transport and delivery under physio-
        synthesis. In contrast to the “structural” hemoglobinopathies (e.g.,   logic conditions. Free or “unpaired” α-, β-, and γ-globin chains are

        546
   639   640   641   642   643   644   645   646   647   648   649